Europe Gene Synthesis (research Use) Market Size & Outlook

The gene synthesis (research use) market in Europe is expected to reach a projected revenue of US$ 998.9 million by 2030. A compound annual growth rate of 15.7% is expected of Europe gene synthesis (research use) market from 2023 to 2030.
Revenue, 2022 (US$M)
$310.6
Forecast, 2030 (US$M)
$998.9
CAGR, 2023 - 2030
15.7%
Report Coverage
Europe

Europe gene synthesis (research use) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe gene synthesis (research use) market, 2018-2030 (US$M)

Related Markets

Europe gene synthesis (research use) market highlights

  • The Europe gene synthesis (research use) market generated a revenue of USD 310.6 million in 2022.
  • The market is expected to grow at a CAGR of 15.7% from 2023 to 2030.
  • In terms of segment, solid-phase synthesis was the largest revenue generating method in 2022.
  • PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.
  • Country-wise, Netherlands is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 310.6 million
Market revenue in 2030USD 998.9 million
Growth rate15.7% (CAGR from 2022 to 2030)
Largest segmentSolid-phase synthesis
Fastest growing segmentPCR-based Enzyme Synthesis
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSolid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis
Key market players worldwideGenScript ProBio, Azenta Inc, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, NanHua Bio-medicine, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies, ProMab Biotechnologies Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 19.8% of the global gene synthesis (research use) market in 2022.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,052.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Synthesis (Research Use) Market Companies

Name Profile # Employees HQ Website

Europe gene synthesis (research use) market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis (research use) market will help companies and investors design strategic landscapes.


Solid-phase synthesis was the largest segment with a revenue share of 38.25% in 2022. Horizon Databook has segmented the Europe gene synthesis (research use) market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe gene synthesis (research use) market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe gene synthesis (research use) market databook

  • Our clientele includes a mix of gene synthesis (research use) market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe gene synthesis (research use) market, including forecasts for subscribers. This continent databook contains high-level insights into Europe gene synthesis (research use) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe gene synthesis research use market report size, by country, 2018-2030 (US$M)

Europe Gene Synthesis (Research Use) Market Share, 2022 & 2030 (US$M)

Europe gene synthesis research use market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more